Tenaxis Medical
Founded Year
2004Stage
Debt - V | AliveTotal Raised
$33.25MLast Raised
$1.38M | 9 yrs agoAbout Tenaxis Medical
Tenaxis Medical develops and commercializes high-performance sealants and anti-adhesion agents for use in vascular and general surgery. The company's primary focus is to create products that meet unfulfilled needs in these fields. Its first product, ArterX Surgical Sealant, is based upon a crosslinking agent that covalently binds to proteins in both the sealant and human tissue.
Missing: Tenaxis Medical's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Tenaxis Medical's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Tenaxis Medical Patents
Tenaxis Medical has filed 6 patents.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
10/16/2013 | 5/7/2019 | Dicarboxylic acids, Biomaterials, Aldehydes, Polymers, Monomers | Grant |
Application Date | 10/16/2013 |
|---|---|
Grant Date | 5/7/2019 |
Title | |
Related Topics | Dicarboxylic acids, Biomaterials, Aldehydes, Polymers, Monomers |
Status | Grant |
Latest Tenaxis Medical News
Feb 7, 2014
February 7, 2014 by Chris Walker Tenaxis Medical hauls in more than $1 million in a still-open funding round. Tenaxis Medical said it brought in close to $1.4 million in a still-open funding round. The Mountain View, Calif.-based medical device company develops and commercializes surgical sealants for vascular and general procedures. Sign up to get our free newsletters delivered straight to your inbox Tenaxis' marquee product, the ArterX sealant for vascular procedures, uses a prophylactic agent that binds to proteins in both the sealant and the tissue to cross-link them. The sealant has won approval in the U.S. and Europe, according to the Tenaxis website . The debts-and-warrants round already involves some 30 unnamed investors, according to a regulatory filing . Tenaxis is hoping to raise total of $1.5 million, according to the filing.
Tenaxis Medical Frequently Asked Questions (FAQ)
When was Tenaxis Medical founded?
Tenaxis Medical was founded in 2004.
Where is Tenaxis Medical's headquarters?
Tenaxis Medical's headquarters is located at 835 Maude Avenue, Mountain View.
What is Tenaxis Medical's latest funding round?
Tenaxis Medical's latest funding round is Debt - V.
How much did Tenaxis Medical raise?
Tenaxis Medical raised a total of $33.25M.
Who are the investors of Tenaxis Medical?
Investors of Tenaxis Medical include Magic Venture Capital and Matrix Medical Network.
Who are Tenaxis Medical's competitors?
Competitors of Tenaxis Medical include IlluminOss Medical, MAKO Surgical, Vibrynt, Aragon Surgical, Symbios Medical Products and 12 more.
Compare Tenaxis Medical to Competitors
Vibrynt is a medical device company developing an implant for the treatment of morbid obesity.
Axis Surgical Technologies, Inc. aims to develop, manufacture, and market devices that improve quality and efficiency in spinal surgery, especially for minimally invasive surgical techniques. Based in Mountain View, California, Axis offers an integration of visualization and articulation capabilities and provides spinal surgery equipment. Axis' FDA Grant In March 2010, Axis announced that it received 510(k) clearance from the Food and Drug Administration to market its C-MOR„ Visualization Device to use in diagnostic and operative arthroscopic and endoscopic procedures. This portable tool provides visualization and illumination of an interior cavity through either a natural or surgical opening. The ergonomic lightweight device also offers practitioners the convenience of endoscopic visualization and efficient one-handed operating ability; this device can be employed in hospital outpatient departments, ambulatory surgery centers, and office surgery suites.
Focal develops, manufactures and commercializes synthetic, absorbable, liquid surgical sealants based on the company's polymer technology. The company's FocalSeal-L and FocalSeal-S surgical sealant products are currently being developed for use inside the body to seal leaks resulting from lung, neurological, cardiovascular and gastrointestinal surgery.
ClearMedical is a distributor of remanufactured brand name surgical devices. ClearMedical aims to drive cost savings by selling high-volume, disposable, FDA approved laparoscopic, arthroscopic, and general surgical devices at reduced prices. The company collects used Single-Use-Devices (SUDs) from hospitals, reprocesses them consistent with FDA approvals, and sells them to hospitals and surgery centers wanting to reduce supply acquisition costs. The company's device list includes harmonic scalpels from Ethicon, trocars from Ethicon, US Surgical (AutoSuture), laparoscopic instruments from Ethicon, US Surgical (AutoSuture), clip appliers from ethicon, US Surgical (AutoSuture), linear cutter and staplers from Ethicon, and bone shavers from Linvatec, Smith & Nephew, and Stryker.
ES Vascular Ltd. developed first ever surgical stapling devices for endovascular surgery. These devices aim to transform vascular surgery by shortening procedural times, and by simplifying and potentially increasing the safety of the most common vascular interventions. The company is currently developing three product lines for open AAA, endovascular AAA and Femoro-Pop bypass procedures. Its first products are anticipated to enter the market in 2008.nCompany Snapshotn Started in 2000 in Israel by Prof. Shifrin together with group of engineers and leading vascular surgeons from the US and Europe;n Developed a ever vascular stapling technology for stapling synthetic grafts to the aortan Developed endovascular devices for EVAR and SFA procedures
iBalance, Inc. is developing an improved method for completing an orthopedic surgical procedure called high tibial osteotomy. The company aims to provide the surgical tools and implant for this knee malalignment corrective surgery.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.